PHILADELPHIA — The American Association for Cancer Research is the recipient of six Telly Awards: one coveted silver award for its 2012 Annual Meeting video and five bronze awards. “It is a tremendous honor for the AACR to have received numerous accolades for our important educational videos...
Posted to
News
by
AACR News
on
Fri, Jun 8 2012
Filed under:
Filed under: Press Releases, Research, Breast Cancer, video, Cancer, Media Materials, AACR, American Association for Cancer Research, award, neuroblastoma, CML, Annual Meeting, AACR Annual Meeting 2012, HER2-positive breast cancer, chronic myeloid leukemia, Telly Awards
Patients with lung cancer and KRAS mutation responded well to antifolate therapy. Response linked to downregulation of KRAS expression. Downregulation may render cells more susceptible to chemotherapeutic drug. CHICAGO — Testing patients with non-small cell lung cancer for both mutations and amplifications...
Posted to
News
by
AACR News
on
Wed, Apr 4 2012
Filed under:
Filed under: Press Releases, Research, Cancer, Media Materials, AACR, lung cancer, American Association for Cancer Research, meeting, KRAS, non-small cell lung cancer, pemetrexed, Dr. Sarah Bacus, 2012 Annual Meeting, Annual Meeting, AACR Annual Meeting 2012, antifolate
Patients with nonprogressive disease had improved survival rates. Five-year survival rate for stage 3B/4 patients was 50 percent. CHICAGO — Long-term follow-up of a phase II clinical trial showed encouraging survival in some patients with stage 3B/4 non-small cell lung cancer treated with...
Posted to
News
by
AACR News
on
Wed, Apr 4 2012
Filed under:
Filed under: Press Releases, Research, Cancer, Media Materials, AACR, lung cancer, American Association for Cancer Research, meeting, Vaccine, non-small cell lung cancer, 2012 Annual Meeting, Annual Meeting, AACR Annual Meeting 2012, belagenpumatucel-L, Dr. Lyudmila Bazhenova
High hormone levels linked to longer survival regardless of treatment. Biomarker provided meaningful method for patient stratification. Data should inform future clinical trial design. CHICAGO — Patients with castration-resistant prostate cancer treated with the androgen inhibitor abiraterone and...
Posted to
News
by
AACR News
on
Tue, Apr 3 2012
Filed under:
Filed under: Press Releases, Research, Cancer, Media Materials, AACR, American Association for Cancer Research, prostate cancer, meeting, 2012 Annual Meeting, Annual Meeting, AACR Annual Meeting 2012, Dr. Charles J. Ryan
Fifty-one percent of people who have had cancer died from cancer. Forty-nine percent of cancer survivors died from other conditions. Researchers encourage a more comprehensive approach to survivor health. CHICAGO — Although cancer recurrence may be the overriding fear for many survivors, nearly...
Posted to
News
by
AACR News
on
Tue, Apr 3 2012
Filed under:
Filed under: Press Releases, Research, Cancer, Media Materials, AACR, American Association for Cancer Research, cancer survivors, meeting, 2012 Annual Meeting, Annual Meeting, AACR Annual Meeting 2012, Dr. Yi Ning
Disease prevalence similar between Hispanics in Puerto Rico and California. Researchers suggest that biology of disease drives tumor behavior. Expression of estrogen receptor associated with better prognosis. CHICAGO — Hispanic women in Puerto Rico who have triple-negative breast cancer share similar...
Posted to
News
by
AACR News
on
Tue, Apr 3 2012
Filed under:
Filed under: Press Releases, Research, Breast Cancer, Cancer, Media Materials, AACR, American Association for Cancer Research, women, meeting, triple-negative breast cancer, 2012 Annual Meeting, Annual Meeting, AACR Annual Meeting 2012, Dr. Edna M. Mora
Intake associated with decreased mortality and recurrence rates. Dose–response relationship observed. Researchers recommend survivors eat more cruciferous vegetables. CHICAGO — Eating cruciferous vegetables after breast cancer diagnosis was associated with improved survival among Chinese...
Posted to
News
by
AACR News
on
Tue, Apr 3 2012
Filed under:
Filed under: Press Releases, Research, Breast Cancer, Cancer, Media Materials, AACR, American Association for Cancer Research, meeting, 2012 Annual Meeting, Annual Meeting, AACR Annual Meeting 2012, Dr. Sarah J. Nechuta, breast cancer survival, vegetables
Risk for prostate cancer recurrence increased as excess body weight increased. Obese and overweight men were at higher risk. Body weight status and related lifestyle factors could be used to predict risk. CHICAGO — Researchers have found an association between excess body weight and an increased...
Posted to
News
by
AACR News
on
Tue, Apr 3 2012
Filed under:
Filed under: Press Releases, Research, Cancer, Media Materials, AACR, American Association for Cancer Research, prostate cancer, meeting, cancer risk, 2012 Annual Meeting, Annual Meeting, AACR Annual Meeting 2012, weight, Dr. Vincent L. Freeman
Caffeine and exercise decreased risk for sunlight-caused skin cancers in mice. Results suggest that fat and tumor growth are related. Findings link caffeine and exercise with lower levels of inflammation. CHICAGO — The combined effects of exercise plus caffeine consumption may be able to ward off...
Posted to
News
by
AACR News
on
Tue, Apr 3 2012
Filed under:
Filed under: Press Releases, Research, exercise, Cancer, Media Materials, AACR, American Association for Cancer Research, meeting, skin cancer, sunlight, caffeine, 2012 Annual Meeting, Annual Meeting, AACR Annual Meeting 2012, Dr. Yao-Ping Lu
Patients did not have to adjust lifestyle or common drugs for this test. Age affected four methylation markers studied, but to different extents. Selecting optimal methylation markers may minimize false positives. CHICAGO — Research on an investigational DNA methylation test for colorectal cancer...
Posted to
News
by
AACR News
on
Tue, Apr 3 2012
Filed under:
Filed under: Press Releases, Research, Cancer, Media Materials, AACR, American Association for Cancer Research, colorectal cancer, meeting, 2012 Annual Meeting, Annual Meeting, AACR Annual Meeting 2012, Dr. David Ahlquist, colorectal cancer test, DNA methylation test, noninvasive stool test
Nab-paclitaxel and carboplatin yielded a 41 percent response rate. Toxicity of the combination is “tolerable.” CHICAGO — A combination of nab-paclitaxel and carboplatin for the treatment of non-small cell lung cancer may be a promising option for patients ineligible for treatment with bevacizumab, according...
Posted to
News
by
AACR News
on
Tue, Apr 3 2012
Filed under:
Filed under: Press Releases, Cancer, Media Materials, AACR, lung cancer, American Association for Cancer Research, non-small cell lung cancer, NSCLC, 2012 Annual Meeting, Annual Meeting, nab-paclitaxel, AACR Annual Meeting 2012, carboplatin, Dr. Gregory A. Otterson
Connaught strain of bacillus Calmette-Guérin proved superior. Patients treated with Tice strain may be at increased risk for recurrence. Genetic strain differences rather than dose and preparation at cause. CHICAGO — Use of the Connaught strain of bacillus Calmette-Guérin, an adjuvant...
Posted to
News
by
AACR News
on
Mon, Apr 2 2012
Filed under:
Filed under: Press Releases, Research, Cancer, Media Materials, AACR, American Association for Cancer Research, meeting, bladder cancer, 2012 Annual Meeting, Annual Meeting, AACR Annual Meeting 2012, non-muscle-invasive bladder cancer, Connaught strain, Dr. Cyrill A. Rentsch, Phase III trial, bacillus Calmette-Guérin
Frank McCormick, Ph.D., F.R.S., D.Sc. (hon.), is president. Judy E. Garber, M.D., M.P.H., is now past-president. Charles L. Sawyers, M.D., is inaugurated as president-elect. CHICAGO — The AACR welcomes its new leadership as Frank McCormick, Ph.D., F.R.S., D.Sc. (hon.), assumes the role of president...
Posted to
News
by
AACR News
on
Mon, Apr 2 2012
Filed under:
Filed under: Press Releases, Research, Leadership, Cancer, Media Materials, AACR, American Association for Cancer Research, meeting, 2012 Annual Meeting, Annual Meeting, AACR Annual Meeting 2012
Tumor burden reduction and disease stabilization occurred in some cases. Tremelimumab also reduced blood levels of hepatitis C virus. CHICAGO — Tremelimumab treatment stabilized patients with advanced hepatocellular carcinoma due to chronic hepatitis C infection for more than 12 months, according...
Posted to
News
by
AACR News
on
Mon, Apr 2 2012
Filed under:
Filed under: Press Releases, Research, Treatment, Cancer, Media Materials, AACR, American Association for Cancer Research, meeting, 2012 Annual Meeting, Annual Meeting, AACR Annual Meeting 2012, liver cancer, heptaocellular carcinoma, hepatitis C virus, Dr. Ignacio Melero, tremelimumab
Patients with breast cancer responded well to vaccine for recurrence prevention. T regulatory cells decreased in patients assigned to the vaccine. Immunologic testing may help identify responders to peptide vaccine. CHICAGO — Patients with breast cancer assigned to the HER2-based peptide vaccine...
Posted to
News
by
AACR News
on
Mon, Apr 2 2012
Filed under:
Filed under: Press Releases, Research, Breast Cancer, Cancer, Media Materials, AACR, American Association for Cancer Research, meeting, Vaccine, 2012 Annual Meeting, Annual Meeting, AACR Annual Meeting 2012, peptide, Dr. Diane F. Hale, HER2